APA (7th ed.) Citation

Shadi, M., Satish, P., & W, H. D. (2009). Glycogen synthase kinase-3 inhibition disrupts nuclear factor-kappaB activity in pancreatic cancer, but fails to sensitize to gemcitabine chemotherapy. BMC.

Chicago Style (17th ed.) Citation

Shadi, Mamaghani, Patel Satish, and Hedley David W. Glycogen Synthase Kinase-3 Inhibition Disrupts Nuclear Factor-kappaB Activity in Pancreatic Cancer, but Fails to Sensitize to Gemcitabine Chemotherapy. BMC, 2009.

MLA (9th ed.) Citation

Shadi, Mamaghani, et al. Glycogen Synthase Kinase-3 Inhibition Disrupts Nuclear Factor-kappaB Activity in Pancreatic Cancer, but Fails to Sensitize to Gemcitabine Chemotherapy. BMC, 2009.